Editorial Board Member
Matteo Becatti
Department of Clinical and Experimental Biochemical Sciences, University of Florence, Italy
About
As published by the journal they serve.
Matteo Becatti graduated in Biological Sciences in 2006. In April 2010 he has attained the PhD. Since his graduation he has been devoted to research on the molecular pathways evoked by oxidative stress in several disorders, in particular dermatologic diseases (vitiligo and psoriasis). In 2010 he has demonstrated the pivotal role of p38 MAP kinase as an upstream signal of perilesional keratinocyte damage, and the important contribution of p38 and NF-kB on p53 accumulation (Becatti M et al, Antiox and Redox Signaling, 2010). Furthermore, Matteo Becatti is first author of the first publication that demonstrates the protective role of SIRT1 in vitiligo and its underlying mechanism (Becatti et al, J Cell Mol Med, 2014). He proposed SIRT1 activation as a novel way of protecting perilesional vitiligo keratinocytes from damage. Matteo Becatti is a member of the Società Italiana di Biochimica (SIB) and of the Società Italiana per lo studio dell'emostasi e della trombosi (SISET).
Research interests
Qualifications
PhD
Journals they serve
The seats these journals name them in.
- Clinical Dermatology Research JournalEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.